Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Louis-David Guay
Observed name:
Louis David Guay
Institutions:
PROTEO,
Université Laval,
Centre de recherche du CHU de Québec-Université Laval
Observed institutions:
PROTEO,
Université Laval,
Institut sur la nutrition et les aliments fonctionnels (INAF),
Centre de recherche du CHU de Québec-Université Laval,
CHU de Québec-Université Laval
ORCID:
0000-0001-8328-7550
Observed ORCID:
0000-0001-8328-7550
OpenAlex ID:
A5034528425
Works
11
Awards
1
Antimicrobial Activity of Synthetic Enterocins A, B, P, SEK4, and L50, Alone and in Combinations, against Clostridium perfringens
2024
·
Sara García-Vela
, Louis-David Guay
, et al.
·
International Journal of Molecular Sciences
·
30
PDF
Structure–Activity Study of the Antimicrobial Lipopeptide Humimycin A and Screening Against Multidrug-Resistant Staphylococcus aureus
2025
·
Md Ramim Tanver Rahman
, Louis-David Guay
, et al.
·
Antibiotics
·
8
PDF
Synthesis and structure–activity study of the antimicrobial lipopeptide brevibacillin
2024
·
Omar Fliss
, Louis-David Guay
, et al.
·
RSC Medicinal Chemistry
·
8
PDF
Synthesis and biological evaluation of novel 1,4-benzodiazepin-3-one derivatives as potential antitumor agents against prostate cancer
2021
·
Simon Vézina-Dawod
, Martin Perreault
, et al.
·
Bioorganic & Medicinal Chemistry
·
5
Convenient route to Fmoc-homotyrosine via metallaphotoredox catalysis and its use in the total synthesis of anabaenopeptin cyclic peptides
2023
·
Christopher Bérubé
, Louis-David Guay
, et al.
·
Organic & Biomolecular Chemistry
·
4
Exploring the structure-activity relationship of brevibacillin: Discovery of synthetic analogues with an extended spectrum of activity
2025
·
Louis-David Guay
, Florence Henley
, et al.
·
European Journal of Medicinal Chemistry
·
1
Antimicrobial Activity of a Synthetic Brevibacillin Analog Against Multidrug-Resistant Campylobacter spp.
2025
·
Khaled Abdallah
, Omar Fliss
, et al.
·
International Journal of Molecular Sciences
·
1
PDF
Microbiological and genomic approaches to study and characterize co- and cross-resistance to antimicrobial peptides in Listeria monocytogenes ATCC 19,111 variants
2026
·
Omar Fliss
, Louis-David Guay
, et al.
·
BMC Microbiology
Additional file 1 of Microbiological and genomic approaches to study and characterize co- and cross-resistance to antimicrobial peptides in Listeria monocytogenes ATCC 19,111 variants
2026
·
Omar Fliss
, Louis-David Guay
, et al.
·
Figshare
Microbiological and genomic approaches to study and characterize co- and cross-resistance to antimicrobial peptides in Listeria monocytogenes ATCC 19,111 variants
2026
·
Omar Fliss
, Louis-David Guay
, et al.
·
Figshare
Comprehensive Phenotypic and Genomic Study for Understanding the Variability in Susceptibility of Listeria monocytogenes to AMPs and Bacteriocins
2026
·
Omar Fliss
, Louis-David Guay
, et al.
·
Probiotics and Antimicrobial Proteins
Show more works
View as search
Works count:
11
Citation count:
57
H-index:
4
I10-index:
1
Year
Topic
Type